The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human apolipoprotein E. The complete amino acid sequence
Open accessAbstract
The amino acid sequence of human apolipoprotein E (apo-E) has been determined.Apo-E2, one of the major isoforms of apolipoprotein E, is a polypeptide of 299 amino acids having a calculated molecular weight of 34,145.The isoform apo-E3 differs from apo-E2 by a single amino acid substitution of arginine for cysteine at residue 158 (italicized).The sequqnce of apo-E2 is:HzN-Lys-Val-Glu-Gln-Ala-Val-Glu-Thr-Glu-Pro-Glu-Pro-Glu-Leu-Arg-Gln-Gln-Thr-Glu-Trp-Gln-Ser-Gly-Gln-Arg-Trp-Glu-Leu-Ala-Leu-Gly-Arg-Phe-Trp-Asp-Tyr-Leu-Arg-Trp-Val-Gln-%-Leu-Ser-Glu-Gln-Val-Gln-Glu-Glu-Leu-Leu-Ser-Ser-Gln-Val-Thr-Gln-Glu-Leu-Arg-Ala-Leu-Met-Asp-Glu-Thr-Met-Lys-Glu-Leu-Lys-Ala-Tyr-Lys-Ser-Glu-Leu-Glu-Glu-Gln-Leu-Thr-Pro-Val-Ala-Glu-Glu-Thr-Arg-Ala-Arg-Leu-Ser-Lys-Glu-Leu-Gln-Ala-Ala-Gln-Ala-Arg-Leu-Gly-Ala-Asp-Met-Glu-Asp-Val-Cys-Gly-Arg-Leu-Val-Gln-Tyr-Arg-Gly-Glu-Val-Gln-Ala-Met-Leu-Gly-Gln-Ser-Thr-Glu-Glu-Leu-Arg-Val-Arg-Leu-Ala-Ser-His-Leu-Arg-Lys-Leu-Arg-Lys-Arg-Leu-Leu-Arg-Asp-Ala-Asp-Asp-Leu-Gln-Lys-Cys-Leu-Ala-Val-Tyr-Gln-Ala-Gly-Ala-Arg-Glu-Gly-Ala-Glu-Arg-Gly-Leu-Ser-Ala-Ile-Arg-Glu-Arg-Leu-Gly-Pro-Leu-Val-Glu-Gln-Gly-Arg-Val-Arg-Ala-Ala-%-Val-Gly-Ser-Leu-Ala-Gly-Gln-Pro-Leu-Gln-Glu-Arg-Ala-Gln-Ala-Trp-Gly-Glu-Arg-Leu-Arg-Ala-Arg
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common has a mutation of 158 Arg --Cys (13), but mutations of 145 Arg -* Cys (14) and 146 Lys --Gln (6) have also been reported in individuals with type III hyperlipoproteinemia.”
From Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. (1987) · cites this paper as [13]
In the citing paper
“Three variants ofapo E2 have been described.Each ofthese differs from apo E3 by a single amino acid substitution (6, 12- 14).”
From Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. (1987) · cites this paper as [13]
In the citing paper
“Secondary structure predictions (54,55) suggest that position 136 is part of an a-helix that extends between residues 130 and 150 (13,24), encompassing the receptor-binding domain from 140 to 150 (22).”
From Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. (1987) · cites this paper as [13]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [17]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [17]
In the citing paper
“Both codons 112 and 158 showed the amino acid cysteine (Cys) (shown in Fig. 3), which indicated that the isoform of apoE was apoE2/E2 [8, 9].”
In the citing paper
“In normal apoE3, peptide T15 is a 15-residue peptide encompassing residues 120-134 (23).”
From Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127 (1989) · cites this paper as [23]
In the citing paper
“This profile is similar to that for normal apoE3 (17, 23) except for the presence of a new peak (CBX) eluting at the column volume.”
From Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127 (1989) · cites this paper as [23]
Citations
Cites
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a001 · Cited by 2,172
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Self-citationA molecular theory of lipid—protein interactions in the plasma lipoproteins
Segrest, J. P., Jackson, R. L., Morrisett, J. D., & Gotto, A. M. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80064-5 · Cited by 726
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Self-citationWeisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34284-9 · Cited by 616
Self-citationMarshall, R. (1972) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.41.070172.003325 · Cited by 604
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Disturbances in Lipid and Lipoprotein Metabolism
Bouchier, I. A. D. (1978) · Gut · doi:10.1136/gut.19.11.1088 · Cited by 495
Innerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Self-citation
Research works printed but not linked: 2
- Mahley, 1977, Am. J. Pathol., 87, 205
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
Cited by
Sorted by citations
Items 501–600 of 739
Apolipoprotein E genotype in matched men and women with coronary heart disease.
Kolovou, G. D., Anagnostopoulou, K. K., Salpea, K. D., Panagiotakos, D. B., Hoursalas, I. S., Cariolou, M. A., Koniavitou, K., & Cokkinos, D. V. (2005) · PubMed · Cited by 8
Takacs, C. N., Andreo, U., Belote, R. L., Pulupa, J., Scull, M. A., Gleason, C. E., Rice, C. M., & Simon, S. M. (2017) · Traffic · doi:10.1111/tra.12467 · Cited by 10
An increased incidence of apolipoprotein E2/E2 and E4/E4 in retinitis pigmentosa
Huq, L., McLACHLAN, T., Hammer, H. M., Bedford, D. K., Packard, C. J., Shepherd, J., & Converse, C. A. (1993) · Lipids · doi:10.1007/bf02537120 · Cited by 9
Rare apolipoprotein E variant identified in a patient with Type III hyperlipidaemia
Wenham, P. R., McDowell, I., Hodges, V. M., McEneny, J., O’Kane, M., Jérémy, R., Davies, H., Nicholls, D. P., Trimble, E. R., & Blundell, G. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90028-s · Cited by 9
Telci, A., Salmayenli, N., Aydın, A. E., Yamaner, S., Sıvas, A., & Eldegez, U. (1992) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1992.30.12.847 · Cited by 9
[2] Molecular and cell biology of lipoprotein biosynthesis
Driscoll, D. M., & Getz, G. S. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28062-3 · Cited by 9
Callas, N., Poveda, E., Baracaldo, C., Hernández-Rodríguez, P., Castillo, C., & Guerra, M. (2007) · Biomédica · doi:10.7705/biomedica.v27i4.171 · Cited by 9
Venkatramana, P., Reddy, P. C., & Ferrell, R. E. (2001) · International Journal of Human Genetics · doi:10.1080/09723757.2001.11885746 · Cited by 9
Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis
Feussner, G., Bommer, J., & Ziegler, R. (1990) · Journal of Molecular Medicine · doi:10.1007/bf01646845 · Cited by 9
Apolipoprotein E4, Cholinergic Integrity, Synaptic Plasticity and Alzheimer’s Disease
Poirier, J., Delisle, M.-C., Quirion, R., Aubert, I., Rocheford, J., Rousse, I., Gracon, S. I., Farlow, M. R., & Gauthier, S. G. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_3 · Cited by 9
Interactions between TTYH2 and APOE facilitate endosomal lipid transfer
Sukalskaia, A., Karner, A., Pugnetti, A., Weber, F., Plochberger, B., & Dutzler, R. (2025) · Nature · doi:10.1038/s41586-025-09200-x · Cited by 10
Gan, C., Zhang, Y., Zhang, X., Huang, Q., & Guo, X. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s440103 · Cited by 8
Potential genetic biomarkers in the early diagnosisof Alzheimer disease: APOE and BIN1
Kaya, G., Gündüz, E., Acar, M., Hatipoğlu, Ö. F., Acar, B., İlhan, A., & Gündüz, M. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1405-96 · Cited by 8
Bosnian study ofAPOEdistribution (BOSAD): a comparison with other European populations
Adler, G., Adler, M. A., Urbańska, A., Skonieczna‐Żydecka, K., Kiseljaković, E., Valjevac, A., Parczewski, M., & Hadžović-Džuvo, A. (2017) · Annals of Human Biology · doi:10.1080/03014460.2017.1346708 · Cited by 8
Influência genética sobre a doença de Alzheimer de início precoce
Lucatelli, J. F., Barros, A. C., Maluf, S. W., & de Andrade, F. M. (2009) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832009000100004 · Cited by 8
Characterization of apolipoproteins from chicken plasma
Brown, E. M., & Dower, H. J. (1990) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)89486-3 · Cited by 8
A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia
Yamanouchi, Y., Takano, T., Hamaguchi, H., & Tokunaga, K. (2001) · Journal of Human Genetics · doi:10.1007/s100380170014 · Cited by 8
Dong, L.-M., Yamamura, T., Tajima, S., & Yamamoto, A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91321-g · Cited by 8
Fernández‐Miranda, C., Cancelas, P., Sanz, M., Porres, A., & Gerique, J. G. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00552-4 · Cited by 8
Preparative electrophoresis of human apolipoprotein E: an improved method.
Meunier, S., Gambert, P., Desgrès, J., & Lallemant, C. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38745-9 · Cited by 8
Gregg, R. E., & Brewer, H. B. (1986) · Springer eBooks · doi:10.1007/978-1-4684-1262-8_25 · Cited by 8
Tsuchiya, S., Yamanouchi, Y., Miyazaki, R., Yanagi, H., Yamakawa, K., Yuzawa, K., Ohnuki, M., & Hamaguchi, H. (1987) · The Japanese Journal of Human Genetics · doi:10.1007/bf01910283 · Cited by 8
Somatic gene therapy for dyslipidemias
Belalcazar, M., & Chan, L. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90199-3 · Cited by 8
Diabetes and lipoprotein receptors
Kraemer, F. B. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030301 · Cited by 7
Brantmeier, S. A., Grummer, R. R., & AX, R. L. (1988) · Lipids · doi:10.1007/bf02537331 · Cited by 8
Stankovic, S. D., Glišić, S., & Alavanatić, D. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-8899 · Cited by 8
RetractedFeussner, G., Albanese, M., & Valencia, A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05870-4 · Cited by 7
Touré, M., Diouf, N. N., Thiam, S., Diop, J. P. D., Coly, M. S., Mbengue, A., Sar, F. B., Bâ, A., Diallo, F. A., & Samb, A. (2022) · Cureus · doi:10.7759/cureus.24063 · Cited by 7
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis
Rafiei, M., Yeganeh, M. Z., Sheikholeslami, S., Gozalpour, E., Ghaffarpour, M., & Hedayati, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.050 · Cited by 7
Máchal, J., Vašků, A., Hlinomaz, O., Linhartová, P. B., Groch, L., & Vítovec, J. (2012) · Biomedical Papers · doi:10.5507/bp.2012.051 · Cited by 7
Zhong, Z., Wu, H., Wu, H., & Zhao, P. (2018) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2017-0301 · Cited by 8
Detection of apolipoprotein E phenotype in unconcentrated cerebrospinal fluid
Mehta, P. D., Patrick, B. A., Pirttilä, T., Coyle, P. K., & Aisen, P. S. S. (2003) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10063 · Cited by 7
Analytical procedures for the detection and characterization of apolipoprotein E mutants
Assmann, G., Funke, H., & Jabs, H.-U. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90639-9 · Cited by 7
Groß, W., & März, W. (1999) · Analytica Chimica Acta · doi:10.1016/s0003-2670(98)00497-8 · Cited by 7
Gustafson, S., Vessby, B. O., & Östlund‐Lindqvist, A. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90234-7 · Cited by 7
The sequence of porcine apolipoprotein E (APOE) cDNA
Brzozowska, A., Grimholt, U., Kulseth, M. A., Wold, I., & Rogne, S. (1993) · DNA sequence · doi:10.3109/10425179309015633 · Cited by 7
Chapter 12 Lipoprotein genetics and molecular biology
Breslow, J. L. (1987) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60206-9 · Cited by 7
Mazzone, T., Papagiannes, E., & Magner, J. A. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90190-6 · Cited by 7
[31] Immunochemical methods for studying lipoprotein structure
Krul, E. S., & Schonfeld, G. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28091-x · Cited by 7
Charge distributions and amphipathicity of receptor-binding alpha-helices
Dohlman, J. G., Loof, H. D., & Segrest, J. P. (1990) · Molecular Immunology · doi:10.1016/0161-5890(90)90124-i · Cited by 7
Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease
Hone, E., Lim, F., & Martins, I. J. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch7 · Cited by 8
Apolipoprotein E: Receptor Binding Properties
Weisgraber, K. H., Innerarity, T. L., Rall, S. C., & Mahley, R. W. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2459-1_13 · Cited by 7
Self-citationMartins, I. J., Gupta, V. B., Wilson, A. C., Fuller, S. J., & Martins, R. N. (2014) · Current Proteomics · doi:10.2174/157016461103140922163729 · Cited by 7
Depressive symptoms and APOE polymorphisms in an elderly population-based sample
García‐Peña, C., Juárez‐Cedillo, T., Cruz‐Robles, D., Fragoso, J. M., Sánchez‐García, S., Rodrı́guez-Pérez, J. M., Gallo, J. J., Wagner, F. A., & Vargas‐Alarcón, G. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a211a · Cited by 6
Apolipoprotein E and Amyloid-β-Independent Mechanisms in Alzheimer’s Disease
Kanekiyo, T., & Bu, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00006-1 · Cited by 6
Hu, X., Xie, Z., Zan, X., Ma, L., Li, H., You, C., & Jiang, Y. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.07.019 · Cited by 6
On the mechanism of cholesterol interaction with apolipoproteins A-I and E
Klimov, A. N., Kozhevnikova, K. A., Klueva, N. N., & Belova, E. V. (1992) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(92)90060-3 · Cited by 6
Reales, G., Hernández, C. L., Dugoujon, J., Novelletto, A., Cuesta, P., Fortes‐Lima, C., Rodríguez, N., & Calderón, R. (2014) · Annals of Human Biology · doi:10.3109/03014460.2013.877966 · Cited by 6
Isolation and characterisation of a variant allele of the gene for human Apolipoprotein E
Gill, L., Peoples, O. P., Pearston, D. H., Robertson, F. W., Humphries, S. E., Cumming, A., & Hardman, N. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91750-4 · Cited by 6
Michael, J., & Shaw, K. V. (2017) · CRC Press eBooks · doi:10.1201/9780203748831-11 · Cited by 6
Shiwaku, K., Gao, T., Hojo, N., Fukushima, T., & Yamane, Y. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00035-2 · Cited by 6
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins
Ventura, P., Panini, R., Rosa, M. C., Gaetti, E., & Salvioli, G. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80014-5 · Cited by 6
Awad, N. S., & El-Tarras, A. E. (2011) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000109 · Cited by 5
Apolipoprotein E4 inhibits γ‐secretase activity via binding to the γ‐secretase complex
Sun, Y., Islam, S., Gao, Y., Nakamura, T., Zou, K., & Michikawa, M. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15750 · Cited by 5
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00004-2 · Cited by 6
Apolipoprotein E polymorphisms in Mexican patients with coronary artery disease
Gamboa, R., Huesca‐Gómez, C., Pérez-Méndez, O. A., Cruz‐Robles, D., Fragoso, J. M., Juárez‐Cedillo, T., Vallejo, M., Posadas‐Romero, C., & Vargas‐Alarcón, G. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.077 · Cited by 5
Apolipoprotein E3Basel: new insights into a highly conserved protein region
Miserez, A. R., Scharnagl, H., Muller, P. Y., Mirsaidi, R., Stähelin, H. B., Monsch, A. U., März, W., & Hoffmann, M. M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01180.x · Cited by 5
Park, H., Park, K. U., Kim, K.-W., Song, J., Chang, H. E., Heo, S. R., Lee, H. J., & Kim, J. Q. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.075 · Cited by 5
Monoclonal antibodies to serum lipoproteins: Their present and future use in biology and medicine
Watt, R. M., Carhart, R. L., Gentile, T., & Watt, T. S. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90081-6 · Cited by 5
Liu, Y., Wu, J., Shi, Q., Guo, H., Ying, H., & Xu, N. (2014) · BioMed Research International · doi:10.1155/2014/410480 · Cited by 5
(2001) · PubMed · Cited by 5
Cholesterol—A Janus-Faced Molecule in the Central Nervous System
Wood, W. G., Igbavboa, U., Eckert, G. P., & Müller, W. E. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30380-2_7 · Cited by 5
Stankovic, S. D., Glišić, S., & Alavantić, D. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.079 · Cited by 5
RetractedLaplaud, P. M., Beaubatie, L., Rall, S. C., & Maurel, D. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38630-2 · Cited by 5
Self-citationCase Report: A Pediatric Case of Lipoprotein Glomerulopathy in China and Literature Review
Song, Y., Yang, C., Liu, L., & Wang, H. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.684814 · Cited by 5
Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
Tripathi, S., Sharma, Y., & Kumar, D. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037326839241014054430 · Cited by 5
Lissaman, R., Anjum, S., Quaiattini, A., & Rajah, M. N. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100364 · Cited by 5
Investigation of Domain Interaction in the Apolipoprotein E Isoforms by HDX-MS
Pal, S., Dolai, S., Deepa, S., & Garai, K. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169036 · Cited by 5
Role of Apolipoprotein E in Febrile Convulsion
Giray, Ö., Ülgenalp, A., Bora, E., Uran, N., Yılmaz, E., Ünalp, A., & Erçal, D. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.06.014 · Cited by 4
Apolipoprotein E gene polymorphism influenced glycemic status among Malaysians
Rahman, K. M. H., Hossain, M. S., Haque, N., Razak, T. B. A., & Ahmad, H. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i7.557 · Cited by 4
Crystal structure of a proteolytically cleaved, amino terminal domain of apolipoprotein E3
McPherson, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.117 · Cited by 4
In vivo metabolism of apolipoprotein E in humans
Gregg, R. E., & Brewer, H. B. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)29087-4 · Cited by 4
Restriction Isotyping of Apolipoprotein E among Populations of Punjab, Northwestern India
Balgir, P. P., & Kaur, M. (2003) · Human Biology · doi:10.1353/hub.2003.0068 · Cited by 4
Influência genética sobre a doença de Alzheimer de início tardio
Barros, A. C., Lucatelli, J. F., Maluf, S. W., & de Andrade, F. M. (2009) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832009000100003 · Cited by 4
Ikeuchi, R., SAKUMA, N., Hayano, J., & Fujinami, T. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01161-2 · Cited by 4
CYSTEAMINE IN TREATMENT OF TYPE III HYPERLIPIDAEMIA?
Fisher, E. A. A., & Gahl, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92789-1 · Cited by 4
Immunological discrimination between the human apolipoprotein E2(Arg158—-Cys) and E3 isoforms.
Gerritse, K., de Knijff, P., van Ierssel, G., Havekes, L. M., Frants, R. R., Schellekens, M. M., Zegers, N. D., Claassen, E., & Boersma, W. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41547-0 · Cited by 4
Oncogenic parallels in Alzheimer disease
Raina, A. K., Garrett, M. R., Previll, L. A., Obrenovich, M. E., Hartzler, A., Webber, K. M., Casadesús, G., Lee, H., Perry, G. L., Zhu, X., et al. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 4
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
Hamid, M., Sabzghabaee, A. M., Mousavian, Z., Saadatnia, M., Shirani, S., & Moazen, F. (2011) · PubMed Central · Cited by 3
Association between Apolipoprotein E Variants and Obesity-Related Traits in Mexican School Children
Rodríguez‐Carmona, Y., Pérez‐Rodríguez, M., Gámez-Valdez, E., López‐Alavez, F. J., Hernández-Armenta, C. I., Vega-Monter, N., Leyva-García, G., Monge-Cázares, T., Valencia, D. B., Monroy, M. B., et al. (2014) · Lifestyle Genomics · doi:10.1159/000381345 · Cited by 3
Feussner, G., & Ziegler, R. (1992) · The Clinical Investigator · doi:10.1007/bf00184806 · Cited by 3
Apolipoproteína E e Doença de Alzheimer
Prado, D., & Cardoso, I. L. (2013) · Revista Neurociências · doi:10.4181/rnc.2013.21.775.8p · Cited by 3
Risk Factors for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00002-1 · Cited by 4
Hazarika, L., Sen, S., Zawar, A., & Doshi, J. (2021) · Journal of Drug Design and Medicinal Chemistry · doi:10.11648/j.jddmc.20210702.11 · Cited by 3
Fungwe, T. V. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(99)00015-7 · Cited by 3
Maulik, P. R., Reed, R. A., Sparrow, D. A., Sparrow, J. T., & Shipley, G. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40257-3 · Cited by 3
A competitive reverse transcription-PCR to study apolipoprotein epsilon gene expression.
Rexin, M., & Feussner, G. (1998) · PubMed · Cited by 3
Cloning and expression of apolipoprotein E3 and its variant apoE2 and apoE4
Yiqiang, Z., Liu, Z., Hao, B., Yanyi, Y., Jianli, G., & Qu, S. (2006) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/bf02828023 · Cited by 3
The rat, a useful animal model for pharmacological studies on apolipoprotein E
Leininger‐Muller, B., & Siest, G. (1996) · Life Sciences · doi:10.1016/0024-3205(95)02245-7 · Cited by 3
A competitive reverse transcription–PCR to study apolipoprotein ε gene expression
Rexin, M., & Feussner, G. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.4.773 · Cited by 3
Koshino, A., Takaeda, C., Matsuno, T., Kitajima, S., Iwata, Y., Sakai, N., Nagahama, K., Niida, Y., Saito, T., Yokoyama, H., et al. (2022) · Case Reports in Nephrology and Dialysis · doi:10.1159/000525086 · Cited by 2
Apolipoprotein E Mutants, Hyperlipidemia and Arteriosclerosis
Utermann, G. (1985) · Drugs Affecting Lipid Metabolism VIII · doi:10.1007/978-1-4613-2459-1_14 · Cited by 24
PolyGR-containing aggregates link with pathology and clinical features of Alzheimer’s disease
Phuong, H. T., Tomas, R. F., Akmese, C., Mijares, A. M. P., Gerstin, I. M., Guo, S., Bell, L. R., Ellwood, R., Yegorova, S., Ng, S. K., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02954-8 · Cited by 2
Structural signature of plasma proteins classifies the status of Alzheimer’s disease
Son, A., Kim, H., Diedrich, J. K., Bamberger, C., Wilkins, H., Burns, J. M., Morris, J. K., Rissman, R. A., Swerdlow, R. H., & Yates, J. R. (2026) · Nature Aging · doi:10.1038/s43587-026-01078-2 · Cited by 4
Fagla, B. M., York, J. M., Christensen, A., Rosa, C. D., Balu, D., Pike, C. J., Tai, L. M., & Buhimschi, I. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-66489-w · Cited by 2
Three Dimensional Structures of Carbohydrates and Glycoinformatics: An Overview
Veluraja, K., Selvin, J. F. A., Jasmine, A., & Christlet, T. H. T. (2018) · Springer eBooks · doi:10.1007/978-981-10-7483-7_4 · Cited by 2
Nascimento, T. B. R., Glaner, M. F., & Nóbrega, O. D. T. (2012) · Brazilian Journal of Kinanthropometry and Human Performance · doi:10.5007/1980-0037.2012v14n2p221 · Cited by 2
The role of ligand-receptor interactions in disease
Vermeer, B. J., & Leuven, J. A. G. (1990) · Journal of Dermatological Science · doi:10.1016/0923-1811(90)90216-z · Cited by 2
Evaluation of Lathyrus spp. Germplasm for Quality Traits
Musta, A. E.-Z. M. A., Badr, S. A., ., W. T., & ., R. H. A. S. (2007) · Journal of Biological Sciences · doi:10.3923/jbs.2007.1339.1346 · Cited by 2
Dobmeyer, J., Rexin, M., Dobmeyer, T. S., Klein, S., Rossol, R., & Feussner, G. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00046-1 · Cited by 2
Metadata
- Authors
- Rall, S. C., Weisgraber, K. H., & Mahley, R. W.
- ORCID
- Mahley, R W
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1982-04
- Volume
- 257
- Issue
- 8
- Pages
- 4171-4178
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1736154854
- Cited by
- 741
- References
- 38
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 9 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 12 · 2019: 14 · 2018: 11 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 21 · 2013: 19 · 2012: 10
- FWCI
- 40.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, amino acid sequence, apolipoprotein E isoforms, single amino acid substitution, protein sequences
- MeSH terms
- Amino Acid Sequence, Apolipoproteins, Apolipoproteins E, Carboxypeptidases, Cyanogen Bromide, Humans, Lipoproteins, LDL, Models, Molecular, Molecular Weight, Peptide Fragments, Protein Conformation, Carboxypeptidases A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
